Back to today’s briefing

Story perspectives

FDA Approves VIZZ Eye Drops for Enhanced Near Vision

8/12/2025

37 4

Summary

Story summary

The FDA has greenlit VIZZ, a groundbreaking eye drop that promises to enhance near vision for up to 10 hours with just one daily application. Crafted by LENZ Therapeutics, this aceclidine-based solution sidesteps the side effects of earlier treatments. Set to hit U.S. pharmacies by October 2025, it aims to transform the lives of 128 million adults struggling with presbyopia.

1 of 1

Story summary

The FDA has greenlit VIZZ, a groundbreaking eye drop that promises to enhance near vision for up to 10 hours with just one daily application. Crafted by LENZ Therapeutics, this aceclidine-based solution sidesteps the side effects of earlier treatments. Set to hit U.S. pharmacies by October 2025, it aims to transform the lives of 128 million adults struggling with presbyopia.